Why it was recalled
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Product description
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Lot numbers, UPCs & expiration codes
Lot # MHA21825, Exp Date: December 31, 2027
Where it was sold
US Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0259-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Dec 31, 2025
- FDA report date
- Jan 21, 2026
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Alvogen, Inc
Original FDA data
Every field from FDA enforcement report D-0259-2026, exactly as published.
Show all FDA fields
- City
- Morristown
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98225
- Address
- 44 Whippany Rd Ste 300
- Code information
- Lot # MHA21825, Exp Date: December 31, 2027
- Postal code
- 07960-4558
- Report date
- Jan 21, 2026
- Product type
- Drugs
- Recall number
- D-0259-2026
- Classification
- Class II
- Recalling firm
- Alvogen, Inc
- Reason for recall
- Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
- Distribution pattern
- US Nationwide.
- Recall initiation date
- Dec 31, 2025
- Initial firm notification
- Letter
- Center classification date
- Jan 14, 2026